← Back to Search

Treatment 1 - DOT Pattern for Myopia (ASH Trial)

N/A
Waitlist Available
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 minutes
Awards & highlights

ASH Trial Summary

Lag of Accommodation With DOT Spectacle Lenses

Eligible Conditions
  • Myopia

ASH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best vision sphere

ASH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment 1 - DOT PatternExperimental Treatment1 Intervention
Spectacle lens or treatment 1
Group II: Treatment 2 - Control SpectaclesActive Control1 Intervention
Comparator lens or control arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DOT Pattern
2022
N/A
~30

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
1,063 Total Patients Enrolled
10 Trials studying Myopia
1,063 Patients Enrolled for Myopia
University of WaterlooOTHER
123 Previous Clinical Trials
209,448 Total Patients Enrolled
16 Trials studying Myopia
698 Patients Enrolled for Myopia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025